Recent News

• 07.27.2026 - OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results
• 07.27.2026 - OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results
• 07.23.2026 - OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026
• 07.23.2026 - OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026
• 06.15.2026 - Preclinical Data for OPKO Biologics' OPK8801001 in Acromegaly Presented at ENDO 2026
• 06.15.2026 - Preclinical Data for OPKO Biologics' OPK8801001 in Acromegaly Presented at ENDO 2026
• 05.12.2026 - OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies
• 05.12.2026 - OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies
• 04.30.2026 - OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China
• 04.30.2026 - OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China

Recent Filings

• 07.28.2026 - 4 Statement of changes in beneficial ownership of securities
• 07.28.2026 - 4 Statement of changes in beneficial ownership of securities
• 07.27.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 07.27.2026 - 8-K Current report
• 07.27.2026 - EX-99.1 EX-99.1
• 07.01.2026 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 06.22.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.22.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.22.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.22.2026 - 4 Statement of changes in beneficial ownership of securities